Insider Trading Alleged as Sanofi Continues Its Shopping Spree
The Securities and Exchange Commission (SEC) believes that insider trading occurred around Sanofi (SAN FP) 's $11.6 billion deal for Bioverativ Inc...
335 Views
Antitrust Insights for Smaller US Mergers
Non-Reportable ≠Non-ReviewableAcquisitions of U.S. companies that fall below the $80.8 million Hart-Scott-Rodino (HSR) reporting threshold may...
417 Views
SEC and Drugmaker Allergan Reach Settlement over M&A Disclosure Violations
The U.S. Securities and Exchange Commission and drugmaker Allergan Plc (AGN US)Â settled claims that Allergan failed to disclose negotiations with...
511 Views
Mylan N.V. (MYL US): Another Contrarian Pharmaceutical Investment
Mylan Nv (MYL US)Â stock has seen some downward pressure since 2015 after the increased capital expenditure and debt load for acquisitions...
624 Views
Takeda Pharmaceutical - Is M&A the Way Out of Its Problems?
The FT has reported that Takeda Pharmaceutical may be back on the acquisition trail, with a US$15bil war-chest. This puts into the public domain a...
314 Views